利民實業(00229.HK)年度純利跌33.63%至4196萬港元 末期息4港仙
格隆匯3月26日丨利民實業(00229.HK)公吿,截至2021年12月31日止12個月,公司實現收入14.34億港元,同比增長11.17%;公司股東應占年度溢利4196萬港元,同比減少33.63%;基本每股盈利8.41港仙,建議派發每股普通股末期股息為4港仙。
在2021財政年度,集團面臨經營成本增加、貨櫃短缺及運輸成本增加的各種挑戰。自2020年11月起,集團還面對人民幣兑美元升值2.28%的問題。儘管存在這些不確定因素,集團的創新技術令公司在下半年推出了更多新產品,使集團在2021全年達到可接受的表現。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.